DANIEL RAYNOR Insider Trading $ANIP ANI PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL RAYNOR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL RAYNOR. DANIEL RAYNOR is Director in NUCO2 INC /DE ($NUCO) and Director in ANI PHARMACEUTICALS INC ($ANIP).
DANIEL RAYNOR in ANI PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL RAYNOR: Director
Holdings: 294,316 shares
Current Value: $18,294,683
Latest Transaction: Mar 19 2018
$ANIP Market Capitalization: $718.77M
$ANIP Previous Close: $62.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DANIEL RAYNOR in ANI PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2018 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 60.62 | 5,313 | 322,074 | 289,003 | 294.3 K to 289 K (-1.81 %) |
| Mar 19 2018 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 61.50 | 1,902 | 116,973 | 294,316 | 296.2 K to 294.3 K (-0.64 %) |
| Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 62.02 | 1,919 | 119,016 | 296,218 | 298.1 K to 296.2 K (-0.64 %) |
| Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 62.59 | 4,117 | 257,683 | 298,137 | 302.3 K to 298.1 K (-1.36 %) |
| Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 61.81 | 14,000 | 865,340 | 302,254 | 316.3 K to 302.3 K (-4.43 %) |
| Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 62.88 | 7,928 | 498,513 | 316,254 | 324.2 K to 316.3 K (-2.45 %) |
| Apr 11 2016 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Option Exercise | A | 40.59 | 2,000 | 81,180 | 2,000 | |
| Apr 11 2016 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Grant | A | 0.00 | 1,000 | 0 | 10,110 | 9.1 K to 10.1 K (+10.98 %) |
| Apr 20 2015 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Option Exercise | A | 68.71 | 1,600 | 109,936 | 1,600 | |
| Apr 20 2015 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Grant | A | 0.00 | 800 | 0 | 9,110 | 8.3 K to 9.1 K (+9.63 %) |
| Mar 16 2015 | ANIP | ANI PHARMACEUTICAL ... | RAYNOR DANIEL | Director | Sell | S | 63.00 | 200,000 | 12,600,000 | 324,182 | 524.2 K to 324.2 K (-38.15 %) |
Page: 1